Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Phase II data lead to phase III initiation for HIV candidate BMS-663068

March 3, 2015

Initiation of clinical trial of TLR7 agonist GS-9620 in HIV-positive patients on ART

March 3, 2015

Combination therapy shows efficiency for HIV/HCV coinfection treatment

March 2, 2015

Inhibition of HIV RNA biogenesis blocks viral replication and avoids viremia rebound

March 2, 2015

Potent antiviral activity seen with maturation inhibitor BMS-955176 in HIV-1-positive patients

Feb. 27, 2015

NRC-AN-019, an Indian TKI for chronic myeloid leukemia patients

Feb. 27, 2015

Favipiravir evaluated in phase II Ebola virus disease trial

Feb. 26, 2015

PaQ device improves glycemia control in patients with diabetes

Feb. 26, 2015

Studies support switching to infliximab biosimilar for Crohn's disease and ulcerative colitis

Feb. 26, 2015

Saroglitazar reverses biochemical manifestations of metabolic syndrome

Feb. 25, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...